A social media post claims that a potential new COVID-19 treatment from Pfizer is just rebranded ivermectin, based on the fact that both drugs are protease inhibitors, a class of drugs that are primarily used to treat HIV and hepatitis C. Many protease inhibitor treatments exist and they are not interchangeable. Ivermectin and the new Pfizer treatment are structurally quite different and would not have the same effect in COVID-19 patients.
Recommendation: 
Sign Up for Public Health Alerts
About Us
The Public Health Communications Collaborative (PHCC) was formed in 2020 to coordinate and amplify public health messaging on COVID-19 and increase Americans’ confidence in guidance from the Centers for Disease Control and Prevention (CDC) and state and local public health officials.
Learn More
Learn More